207 related articles for article (PubMed ID: 26840176)
1. Development of glycan specific lectin based immunoassay for detection of prostate specific antigen.
Bhanushali PB; Badgujar SB; Tripathi MM; Gupta S; Murthy V; Krishnasastry MV; Puri CP
Int J Biol Macromol; 2016 May; 86():468-80. PubMed ID: 26840176
[TBL] [Abstract][Full Text] [Related]
2. An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.
Ishikawa T; Yoneyama T; Tobisawa Y; Hatakeyama S; Kurosawa T; Nakamura K; Narita S; Mitsuzuka K; Duivenvoorden W; Pinthus JH; Hashimoto Y; Koie T; Habuchi T; Arai Y; Ohyama C
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241428
[TBL] [Abstract][Full Text] [Related]
3. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.
Tabarés G; Radcliffe CM; Barrabés S; Ramírez M; Aleixandre RN; Hoesel W; Dwek RA; Rudd PM; Peracaula R; de Llorens R
Glycobiology; 2006 Feb; 16(2):132-45. PubMed ID: 16177264
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of human prostate-specific antigen in a sandwich antibody complex.
Stura EA; Muller BH; Bossus M; Michel S; Jolivet-Reynaud C; Ducancel F
J Mol Biol; 2011 Dec; 414(4):530-44. PubMed ID: 22037582
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy.
Ohyama C; Hosono M; Nitta K; Oh-eda M; Yoshikawa K; Habuchi T; Arai Y; Fukuda M
Glycobiology; 2004 Aug; 14(8):671-9. PubMed ID: 15044396
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen immunosensing based on mixed self-assembled monolayers, camel antibodies and colloidal gold enhanced sandwich assays.
Huang L; Reekmans G; Saerens D; Friedt JM; Frederix F; Francis L; Muyldermans S; Campitelli A; Van Hoof C
Biosens Bioelectron; 2005 Sep; 21(3):483-90. PubMed ID: 16076438
[TBL] [Abstract][Full Text] [Related]
7. Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection.
Ideo H; Kondo J; Nomura T; Nonomura N; Inoue M; Amano J
Sci Rep; 2020 Feb; 10(1):2708. PubMed ID: 32066783
[TBL] [Abstract][Full Text] [Related]
8. Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns.
Meany DL; Zhang Z; Sokoll LJ; Zhang H; Chan DW
J Proteome Res; 2009 Feb; 8(2):613-9. PubMed ID: 19035787
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of the interaction between lectin and serum prostate specific antigen in prostate cancer.
Batabyal SK; Majhi R; Basu PS
Neoplasma; 2009; 56(1):68-71. PubMed ID: 19152248
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results.
Gidwani K; Kekki H; Terävä J; Soukka T; Sundfeldt K; Pettersson K
Mol Aspects Med; 2020 Apr; 72():100831. PubMed ID: 31787337
[TBL] [Abstract][Full Text] [Related]
11. Determining the binding affinities of prostate-specific antigen to lectins: SPR and microarray approaches.
Damborský P; Zámorová M; Katrlík J
Proteomics; 2016 Dec; 16(24):3096-3104. PubMed ID: 27883257
[TBL] [Abstract][Full Text] [Related]
12. Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins.
Peracaula R; Tabarés G; Royle L; Harvey DJ; Dwek RA; Rudd PM; de Llorens R
Glycobiology; 2003 Jun; 13(6):457-70. PubMed ID: 12626390
[TBL] [Abstract][Full Text] [Related]
13. A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia.
Dwek MV; Jenks A; Leathem AJ
Clin Chim Acta; 2010 Dec; 411(23-24):1935-9. PubMed ID: 20708609
[TBL] [Abstract][Full Text] [Related]
14. Lectin Affinity Chromatography for the Discovery of Novel Cancer Glycobiomarkers: A Case Study with PSA Glycoforms and Prostate Cancer.
Llop E; Peracaula R
Methods Mol Biol; 2022; 2370():301-313. PubMed ID: 34611876
[TBL] [Abstract][Full Text] [Related]
15. O-glycosylated clusterin as a sensitive marker for diagnosing early stages of prostate cancer.
Kazuno S; Fujimura T; Fujime M; Miura Y; Ueno T
Prostate; 2021 Feb; 81(3):170-181. PubMed ID: 33347638
[TBL] [Abstract][Full Text] [Related]
16. In vitro affinity maturation of an anti-PSA antibody for prostate cancer diagnostic assay.
Muller BH; Savatier A; L'Hostis G; Costa N; Bossus M; Michel S; Ott C; Becquart L; Ruffion A; Stura EA; Ducancel F
J Mol Biol; 2011 Dec; 414(4):545-62. PubMed ID: 22019475
[TBL] [Abstract][Full Text] [Related]
17. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I.
Robert M; Gibbs BF; Jacobson E; Gagnon C
Biochemistry; 1997 Apr; 36(13):3811-9. PubMed ID: 9092810
[TBL] [Abstract][Full Text] [Related]
18. Strategy for sensitive and specific detection of molecular forms of PSA based on 2DE and kinetic analysis: a step towards diagnosis of prostate cancer.
Kumar V; Hassan MI; Singh AK; Dey S; Singh TP; Yadav S
Clin Chim Acta; 2009 May; 403(1-2):17-22. PubMed ID: 19118539
[TBL] [Abstract][Full Text] [Related]
19. Fast and novel purification method to obtain the prostate specific antigen (PSA) from human seminal plasma.
Acevedo B; Perera Y; Torres E; Pentón D; Ayala M; Gavilondo J
Prostate; 2006 Jul; 66(10):1029-36. PubMed ID: 16598740
[TBL] [Abstract][Full Text] [Related]
20. Purification of human prostatic-specific antigen (hPSA) from seminal plasma by immunoaffinity chromatography using a monoclonal antibody anti total PSA.
Pérez L; Zulueta O; Melchor A; Hernández L; López R; Cazanave J; Béquer D
Hybridoma (Larchmt); 2011 Jun; 30(3):247-51. PubMed ID: 21707359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
